{"id":"bufeniode","rwe":[],"tags":[{"label":"bufeniode","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bufeniod","offLabel":[],"synonyms":["bufeniode","bufeniod","diiodobuphenine","proclival"],"timeline":[],"brandName":"Bufeniod","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bufeniode","explanation":"Imagine bufeniode as a key that fits into a lock on a cell's surface. When it binds to this lock, it triggers a series of events that ultimately help to treat a particular disease or condition. This process is highly specific, allowing bufeniode to target only certain cells or pathways without affecting others.","oneSentence":"Bufeniode is thought to work by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Bufeniode is a small molecule that binds to a specific receptor or enzyme, altering its activity and leading to a downstream effect on cellular signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3045","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUFENIODE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:08:01.444397","biosimilars":[],"competitors":[],"genericName":"bufeniode","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"JC82071PQS","CHEBI":"CHEBI:135827","INN_ID":"2894","UMLSCUI":"C0054206","ChEMBL_ID":"CHEMBL2105461","PUBCHEM_CID":"72087","MESH_SUPPLEMENTAL_RECORD_UI":"C000329"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bufeniode is a small molecule drug in the bufeniode class, but specific details about its development, approval status, and indications are not available. As a result, there is limited information on its commercial status, safety considerations, and pharmacokinetic properties. Further research is needed to understand the target, mechanism of action, and clinical applications of bufeniode. The lack of information on its half-life, bioavailability, and generic manufacturers suggests that it may be a relatively new or experimental compound. Overall, more data is required to fully assess the potential of bufeniode as a therapeutic agent.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}